BIND Therapeutics Announces Closing of Public Offering of Common Stock and … – Business Wire (press release)

BIND Therapeutics Announces Closing of Public Offering of Common Stock and
Business Wire (press release)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced the closing of its previously …
8-K Filing Shows Bind Therapeutics Closes Offering Of StockBenzinga

all 2 news articles

…read more

Scroll to Top